WORLDWIDE MARKETS AND EMERGING TECHNOLOGIES FOR POINT-OF-CARE TESTING

308 Pages | 130 Exhibits | 2009 Analysis | Forecasts Through 2014

Distributor: LSI

Major Topics Include:

• Trends in the global clinical diagnostics market and 2008-2014 market analysis by segment

• Factors driving growth in point-of-care testing

• Hospital POC testing market analysis, including critical care testing, bedside whole blood glucose monitoring, rapid tests, POC coagulation testing, POC cardiac markers, and drugs of abuse rapid tests

• Self-testing market assessment, including whole blood glucose monitoring, coagulation self-testing, pregnancy and fertility testing, home infectious disease and drugs of abuse testing, home cholesterol testing.

• Physician's office laboratory market analysis by segment

• New products and technologies under development for point-of-care testing

• Current and forecast market size (2008-2014), pricing trends, and analysis of competitive factors

• Key business transactions, competitor strategies, and technology portfolio analysis

• In-depth profiles of 30 companies plus detailed coverage of over 250 other competitors

EXECUTIVE SUMMARY & MARKET OVERVIEW

1. Market Overview

1.1 Trends in the Global Clinical Diagnostics Market
1.2 Clinical Diagnostics Market and Technology Trends by Segment
	1.2.1 Clinical Chemistry
	1.2.2 Immunodiagnostics
	1.2.3 Hematology and Coagulation
	1.2.4 Microbiology
	1.2.5 Molecular Diagnostics
1.3 Trends in Laboratory Restructuring and the Organization of Testing
1.4 Factors Driving the Adoption of Point-of-Care Testing
1.5 Regulatory Trends Impacting the Use of Point-of-Care Testing
1.6 Cost and Reimbursement Issues in Point-of-Care Testing
1.7 Quality Control and Quality Assurance Issues in Point-of-Care Testing
1.8 Trends in Self-Monitoring, Disease Screening, Wellness Testing, Risk Assessment and Preventative Testing
1.9 Changes in the Site of Health Care Delivery

Exhibit ES-1: Worldwide POC In-Vitro Diagnostics Market, 2008-2014
Exhibit ES-2: Worldwide POC Test Volume Distribution by Site, 2008-2014
Exhibit ES-3: Worldwide POC Diagnostics Market Trend by Test Site, 2008-2014
Exhibit ES-4: Worldwide Hospital POC Testing Products Market by Segment, 2008-2014
Exhibit ES-5: Worldwide Home/Self-Testing Products Market, 2008-2014
Exhibit ES-6: Global Physician's Office Laboratory Market by Test Segment
Exhibit ES-7: Comparison of POC Market Segment Growth Rates, 2009-2014
Exhibit ES-8: 2008 POC IVD Suppliers' Sales and Market Share

Exhibit 1.1: Worldwide Diagnostics Imaging and IVD Markets
Exhibit 1.2: Trends in Population 65 and Older and Health Expenditures, Selected Countries
Exhibit 1.3: U.S. Surgical Procedure Volume by Site, 2006
Exhibit 1.4: Trends in Adoption of Integrated Chemistry/Immunochemistry Systems in U.S. Hospital Laboratories
Exhibit 1.5: Trend in Hospital and Reference Labs in the U.S., 1996-2008
Exhibit 1.6: Worldwide Clinical Diagnostics Market by Segment, 2008-2014
Exhibit 1.7: Worldwide Clinical Diagnostic Products Market by Region
Exhibit 1.8: Worldwide Clinical Chemistry Market, 2008-2014
Exhibit 1.9: 2008 Worldwide Immunoassay Reagent and Supply Market by Segment
Exhibit 1.10: Worldwide Hematology/Coagulation Testing Products Market, 2008-2014
Exhibit 1.11: Worldwide Microbiology Market by Segment
Exhibit 1.12: Worldwide Molecular Diagnostics Market by Application Segment, 2008-2014
Exhibit 1.13: Number of CLIA-Registered U.S. Clinical Laboratories by Type, 1996-2008
Exhibit 1.14: Key Factors Driving Adoption of POC Testing 
Exhibit 1.15: Trends in CLIA-Waived Labs vs. Total Labs in the U.S., 1998-2008
Exhibit 1.16: Waived Analyte Tests Performed in Clinical Labs
Exhibit 1.17: Waived Analyte Tests Performed by Type of Lab
Exhibit 1.18: Segmentation of Healthcare Costs in the U.S.
Exhibit 1.19: Impact of Preventative Healthcare
Exhibit 1.20: Historical Trends in the Number of Hospitals, Hospital Beds, Hospital Admissions, and Average Hospital Stay
Exhibit 1.21: Trend in the Number of Retail Medical Clinics in the U.S.

2. HOSPITAL-BASED POINT-OF-CARE TESTING PRODUCTS

2.1 Hospital Diagnostic Testing Environment 
	2.1.1 Bedside Critical Care Testing Products Market
	2.1.2 Trends in POC Critical Care Test Volume and Equipment Installed Base
	2.1.3 Existing POC Critical Care Testing Products
	2.1.4 New Technologies Under Development for POC Bedside Critical Care Testing
2.2 Bedside Critical Care Testing Market	
	2.2.1 Bedside Critical Care Testing Market Analysis and Forecast
	2.2.2 Bedside Critical Care Testing Product Suppliers' Sales and Market Shares
	2.2.3 Drivers and Limiters of the Hospital POC Critical Care Testing Products Market
2.3 Hospital Bedside Hemostasis Testing Products Market
	2.3.1 Trends in POC Hemostasis Test Volume and Equipment Installed Base
	2.3.2 Existing POC Hemostasis Testing Products
	2.3.3 New Products and Technologies Under Development for POC Hemostasis Testing
	2.3.4 Hospital-Based POC Hemostasis Testing Market Analysis and Forecast
	2.3.5 Hospital-Based POC Hemostasis Testing Product Suppliers' Sales and Market Shares
	2.3.6 Drivers and Limiters of the Hospital POC Hemostasis Testing Products Market
2.4 Bedside/POC Drugs of Abuse Testing Products Market
	2.4.1 Trends in Bedside/POC Drugs of Abuse Testing
	2.4.2 Existing Bedside/POC Drugs of Abuse Testing Products
	2.4.3 New Bedside/POC Drugs of Abuse Testing Products Under Development
	2.4.4 POC Drugs of Abuse Testing Market Analysis and Forecast
	2.4.5 POC Drugs of Abuse Testing Product Suppliers' Sales and Market Shares
	2.4.6 Drivers and Limiters of the Hospital POC Drugs of Abuse Testing Products Market
2.5 POC Cardiac Marker Testing Products Market Analysis
	2.5.1 Trends in POC Testing for Cardiovascular Disease
	2.5.2 POC Cardiac Marker Products Under Development
	2.5.3 POC Cardiac Marker Market Analysis and Forecast
	2.5.4 POC Cardiac Marker Product Suppliers' Sales and Market Shares
	2.5.5 Drivers and Limiters of the POC Cardiac Marker Testing Products Market
2.6 Other Bedside/POC Testing Products Markets
	2.6.1 POC Infectious Disease Testing Products, Market Analysis and Suppliers
	2.6.2 POC Products and Markets for Hemoglobin and Hematocrit Testing
	2.6.3 Hospital and Institutional Bedside Whole Blood Glucose Monitoring Market
		2.6.3.1 Products for Hospital/Institutional Bedside Whole Blood Glucose Monitoring
		2.6.3.2 Hospital/Institutional Bedside Whole Blood Glucose Monitoring Market Analysis
		2.6.3.3 Drivers and Limiters of the Hospital/Institutional Bedside Whole Blood Glucose Monitoring Products Market 

Exhibit 2.1: Hospital Sites for Clinical Diagnostic Testing in the U.S.
Exhibit 2.2: Clinical Testing Site Distribution for Selected Countries
Exhibit 2.3: Trends in Global Hospital-Based POC In-Vitro Diagnostic Test Volume 
Exhibit 2.4: Trends in Worldwide Hospital POC Test Volume by Analyte Segment
Exhibit 2.5: Trends in Emergency Room Visits and Number of Emergency Rooms in Community Hospitals in the U.S.
Exhibit 2.6: Distribution of Hospital-Based POC Test Volume by Site
Exhibit 2.7: Clinical Factors Driving Usage of Point-of-Care Testing
Exhibit 2.8: Trends in Worldwide POC Blood Gas/Electrolyte/Metabolite Test Volume and Instrument Installed Base
Exhibit 2.9: Existing POC Critical Care Testing Products
Exhibit 2.10: Development-Stage POC Critical Care Testing Products
Exhibit 2.11: Worldwide Market for Hospital POC Critical Care Testing Products
Exhibit 2.12: Worldwide Market for POC Single-Test Cartridge Critical Care Testing Products
Exhibit 2.13: Worldwide Market for POC Multi-Test Cartridge Critical Care Testing Products
Exhibit 2.14: Laboratory Versus POC Critical Care Testing Products Market
Exhibit 2.15: 2008 Worldwide Sales and Market Share for Leading Suppliers of POC Critical Care Testing Products
Exhibit 2.16: 2008 Worldwide Sales and Market Share for Leading Suppliers of POC Critical Care Testing Products by Region
Exhibit 2.17: U.S. Trends in Hospitalizations for Conditions with Indications for Coumadin Therapy 
Exhibit 2.18: Worldwide Coronary Artery Bypass Graft and Heart Valve Replacement Procedures by Region, 2005
Exhibit 2.19: Trends in Diagnosis of Atrial Fibrillation in U.S. Hospital Patients, 1996-2006
Exhibit 2.20: Trends in Worldwide POC Hemostasis Test Volume and Instrument Installed Base
Exhibit 2.21: Existing POC Hemostasis Testing Products
Exhibit 2.22: Worldwide Market for Hospital POC Hemostasis Testing Products
Exhibit 2.23: Worldwide Market for Hospital POC Hemostasis Testing Products by Segment
Exhibit 2.24: Laboratory Versus Hospital-Based POC and Self-Test Hemostasis Products Market, 2008-2014
Exhibit 2.25: 2008 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemostasis Testing Products
Exhibit 2.26: 2008 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemostasis Testing Products by Region
Exhibit 2.27: CMS Decision Memorandum Observations
Exhibit 2.28: Number and Percentage of U.S. ED Visits Involving Illicit Drug Use, 2006
Exhibit 2.29: Existing Hospital POC Drugs of Abuse Testing Products
Exhibit 2.30: Worldwide Market for POC Drugs-of-Abuse Testing Products (Hospital Segment)
Exhibit 2.31: Worldwide Market for Laboratory Versus POC Drugs-of-Abuse Testing Products (Hospital Segment)
Exhibit 2.32: 2008 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Drugs-of-Abuse Testing Products by Region
Exhibit 2.33: Analytical Characteristics of Cardiac Troponin I and T Assays for POC and Laboratory Use*
Exhibit 2.34: Existing Hospital POC Cardiac Marker Testing Products
Exhibit 2.35: New POC Cardiac Marker Testing Products Under Development
Exhibit 2.36: Worldwide Market for POC Cardiac Marker Products
Exhibit 2.37: Worldwide Market for Laboratory Versus POC Cardiac Marker Products
Exhibit 2.38: 2008 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Cardiac Marker Products by Region
Exhibit 2.39: Existing Hospital POC Infectious Disease Testing Products
Exhibit 2.40: Worldwide Market for Hospital POC Infectious Disease Testing Products
Exhibit 2.41: Worldwide Market for Laboratory Versus Hospital POC Infectious Disease Testing Products
Exhibit 2.42: 2008 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Infectious Disease Testing Products by Region
Exhibit 2.43: Worldwide Market for Hospital POC Hemoglobin and Hematocrit Testing Products
Exhibit 2.44: 2008 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemoglobin and Hematocrit Testing Products by Region
Exhibit 2.45: Existing Hospital POC Whole Blood Glucose Monitoring Products
Exhibit 2.46: Worldwide Market for Hospital POC Whole Blood Glucose Products by Segment
Exhibit 2.47: Total Worldwide Market for Hospital POC Whole Blood Glucose Testing Products
Exhibit 2.48: 2008 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Whole Blood Glucose Testing Products by Region

CHAPTER 3: HOME AND SELF-TESTING PRODUCTS

3.1 Whole Blood Glucose Self-Testing Products Market
	3.1.1 Existing Whole Blood Glucose Self-Testing Products
	3.1.2 Development-Stage Whole Blood Glucose Self-Testing Products
		3.1.2.1 Integrated Glucose Testing Devices
		3.1.2.2 Implantable Glucose Monitors
		3.1.2.3 Non-Invasive Glucose Monitoring
	3.1.3 Whole Blood Glucose Self-Testing Products Market Analysis and Forecast
	3.1.4 Whole Blood Glucose Self-Testing Product Suppliers' Sales and Market Shares
	3.1.5 Drivers and Limiters of the Whole Blood Glucose Self-Testing Products Market
3.2 OTC Pregnancy and Fertility Testing Products Market
	3.2.1 Trends in Home Pregnancy and Fertility Testing
	3.2.2 Existing Products for Home Pregnancy and Fertility Testing
	3.2.3 New Products Under Development for Home Pregnancy and Fertility Testing
	3.2.4 OTC Pregnancy and Fertility Testing Products Market Analysis and Forecast
	3.2.5 OTC Pregnancy and Fertility Testing Product Suppliers' Sales and Market Shares
	3.2.6 Drivers and Limiters of the OTC Pregnancy and Fertility Testing Products Market
3.3 Markets for Other Home and Self-Testing Products
	3.3.1 Cholesterol Self-Testing
	3.3.2 Fecal Occult Blood Testing
	3.3.3 Home Drugs of Abuse Testing
	3.3.4 Coagulation Self-Testing 
	3.3.5 Infectious Disease Self-Testing
	3.3.6 Home Heart Failure Monitoring
	3.3.7 Home Thyroid and Anemia Testing

Exhibit 3.1: Global Diabetes Prevalence, 2000-2030
Exhibit 3.2: Frequency of Blood Glucose Testing by Diabetics in the U.S.
Exhibit 3.3: Feature Comparison for Leading Brands and Models of Whole Blood Glucose Self-Testing Products
Exhibit 3.4: Other Suppliers of Glucose Self-Testing Products
Exhibit 3.5: Development-Stage Noninvasive/Minimally Invasive Glucose Monitoring Devices
Exhibit 3.6: Worldwide Market for Whole Blood Glucose Self-Testing Products
Exhibit 3.7: Worldwide Market for Whole Blood Glucose Test Strips, Self-Testing Segment
Exhibit 3.8: Worldwide Market for Lancets Used in Whole Blood Glucose Self-Testing
Exhibit 3.9: Worldwide Market for Whole Blood Glucose Self-Testing Products by Region, 2008-2014
Exhibit 3.10: 2008 Worldwide Sales and Market Shares for Leading Suppliers of Whole Blood Glucose Self-Testing Products
Exhibit 3.11: Home Pregnancy and Fertility Tests 
Exhibit 3.12: Worldwide Market for OTC Pregnancy and Fertility Testing Products, 2008-2014
Exhibit 3.13: Worldwide Market for OTC Pregnancy Testing Products, 2008-2014
Exhibit 3.14: Worldwide Market for OTC Fertility Testing Products, 2008-2014
Exhibit 3.15: U.S. Market for OTC Pregnancy and Fertility Testing Products, 2008-2014
Exhibit 3.16: U.S. Market for OTC Pregnancy Testing Products, 2008-2014
Exhibit 3.17: U.S. Market for OTC Fertility Testing Products, 2008-2014
Exhibit 3.18: European Market for OTC Pregnancy and Fertility Testing Products, 2008-2014
Exhibit 3.19: European Market for OTC Pregnancy Testing Products, 2008-2014
Exhibit 3.20: European Market for OTC Fertility Testing Products, 2008-2014
Exhibit 3.21: Japan/ROW Market for OTC Pregnancy and Fertility Testing Products, 2008-2014
Exhibit 3.22: Japan/ROW Market for OTC Pregnancy Testing Products, 2008-2014
Exhibit 3.23: Japan/ROW Market for OTC Fertility Testing Products, 2008-2014
Exhibit 3.24: Worldwide Sales and Market Share for the Leading Suppliers of OTC Pregnancy and Fertility Testing Products, 2008
Exhibit 3.25: Worldwide Market for OTC Blood Lipid Testing Products, 2008-2014
Exhibit 3.26: Worldwide Sales and Market Share for the Leading Suppliers of OTC Blood Lipid Testing Products, 2008
Exhibit 3.27: Fecal Occult Blood Testing Products Available in the Global Market
Exhibit 3.28: Worldwide Market for Home Drugs of Abuse Testing Products, 2008-2014
Exhibit 3.29: Worldwide Sales and Market Share for the Leading Suppliers of Home Drugs of Abuse Testing Products, 2008
Exhibit 3.30: INR Self-Testing Products Available in the Global Market
Exhibit 3.31: Worldwide Market for PT/INR Self-Testing Products, 2008-2014
Exhibit 3.32: Worldwide Sales and Market Share for the Leading Suppliers of PT/INR Self-Testing Products, 2008

CHAPTER 4: PHYSICIAN'S OFFICE AND OTHER ALTERNATE SITE TESTING PRODUCTS

4.1 Types of Testing Performed in Physician Offices and Other Alternate Sites
4.2 Existing Physician's Office Laboratory Products
4.3 New POL Products Under Development
4.4 Physician's Office Laboratory Market Analysis
4.5 POL Product Suppliers' Sales and Market Shares
4.6 Drivers and Limiters of the Worldwide POL Products Market
4.7 Other Alternate Site Testing Products and Markets

Exhibit 4.1: Trends in the Number of CLIA-Registered Physician's Office and Other Selected Alternate Site Labs in the U.S.
Exhibit 4.2: Health Care Financing Administration, Center for Laboratories, CLIA Statistics for POLs as of December 2008 (POLs by Certificate Type)
Exhibit 4.3: Tests Ordered by Office-Based Physicians in the U.S., 2000-2006
Exhibit 4.4: Physician's Office Laboratory Products
Exhibit 4.5: New Products Under Development for the POL Market
Exhibit 4.6: Worldwide Market for Physician's Office Laboratory Testing Products, 2008-2014
Exhibit 4.7: Worldwide Market for Physician's Office Laboratory Testing Products by Segment, 2008-2014
Exhibit 4.8: Worldwide Sales and Market Share for the Leading Suppliers of POL Chemistry Products, 2008
Exhibit 4.9: Worldwide Sales and Market Share for the Leading Suppliers of POL Immunodiagnostic Products, 2008
Exhibit 4.10: Worldwide Sales and Market Share for the Leading Suppliers of POL Hematology Products, 2008
Exhibit 4.11: Worldwide Sales and Market Share for the Leading Suppliers of POL Rapid Test Kits, 2008
Exhibit 4.12: Worldwide Sales and Market Share for the Leading Suppliers of POL Urinalysis Products, 2008
Exhibit 4.13: Worldwide Sales and Market Share for the Leading Suppliers of POL Allergy Testing Products, 2008
Exhibit 4.14: Worldwide Sales and Market Share for the Leading Suppliers of POL Whole Blood Glucose Testing Products, 2008
Exhibit 4.15: Worldwide Sales and Market Share for the Leading Suppliers of POL Whole Blood Hemoglobin Testing Products, 2008
Exhibit 4.16: Worldwide Sales and Market Share for the Leading Suppliers of POL Glycated Hemoglobin Testing Products, 2008
Exhibit 4.17: Worldwide Sales and Market Share for the Leading Suppliers of POL Coagulation Testing Products, 2008
Exhibit 4.18: Combined Worldwide Sales and Market Shares of Leading Suppliers of Physician's Office Laboratory Products, 2008

CHAPTER 5: COMPETITOR ASSESSMENT

5.1 Overview of Companies in the Global POC Diagnostics Market
5.2 Mergers and Partnerships to Improve Competitive Position
5.3 Technology Portfolio Analysis for Leading POC Diagnostics Companies
5.4 Marketing and Distribution Strategies for the Global POC Diagnostics Market

Exhibit 5.1: Overview of Leading Competitors in the POC Diagnostics Market
Exhibit 5.2: Mergers, Acquisitions, and Partnerships Impacting the POC Diagnostics Market
Exhibit 5.3: Technology Portfolio Analysis for Leading Competitors in the POC Diagnostics Market

CHAPTER 6: COMPANY PROFILES

6.1 Abaxis
6.2 Abbott Laboratories
6.3 Accumetrics
6.4 Alfa Wassermann
6.5 Arkray
6.6 Axis-Shield
6.7 Bayer Diabetes Care
6.8 Beckman Coulter
6.9 Cepheid 
6.10 Dexcom 
6.11 Genzyme
6.12 Helena Labs
6.13 Hemocue
6.14 Home Diagnostics
6.15 IDEXX Laboratories/OPTI Medical
6.16 International Technidyne/Thoratec
6.17 Inverness Medical Innovations
	6.17.1 Biosite
	6.17.2 HemoSense
	6.17.3 Cholestech
6.18 Menarini Diagnostics
6.19 Nanogen/ELITech Group
6.20 OraSure Technologies
6.21 Ortho Clinical Diagnostics/LifeScan
6.22 Phamatech
6.23 Princeton BioMeditech
6.24 QBC Diagnostics/The Drucker Company
6.25 Quidel
6.26 Radiometer A/S
6.27 Response Biomedical
6.28 Roche Diagnostics
6.29 Siemens Diagnostics
6.30 Trinity Biotech

77 Elektronika
A. Menarini Diagnostics
Abaxis
Abbott Laboratories
ABT GmbH
Access Diagnostic Tests UK
Accumetrics
ACON Laboratories
Acro Biotech
Adaltis
Adnavance Technologies
Aerscher Diagnostics
Agamatrix
AiMedics
Akubio
Albertsons
Alfa Scientific Designs
Alfa Wassermann
AllMedicus
Alternecare Health Products
Amazon
American Biomedica
AmerisourceBergen
Ameritest USA
Amgen
Amylin Pharmaceuticals
ANI Biotech
Apex Biotech
Arax
Arkray
Arlington Scientific
AstraZeneca
Atlas Link
Audit Diagnostics
Aventir Biotech
AVL List
Awareness Technology
Azo Products
Axis-Shield
Ballard Medical
Bayer
B. Braun Melsungen
Beckman Coulter
Becton Dickinson
BeneCheck/General Life Biotechnology
Bestgen Biotech
Bio/Data
BioHelix
Biomedical Diagnostics Institute
Biomedix
Biomerica
bioMerieux
Bionime
Bio-Rad Laboratories
Biosafe Laboratories
Biosite Diagnostics
Biosurfit
Biotechnostix
Biotex
BODITECH MED
BodyTel
Boule Diagnostics
B•R•A•H•M•S Aktiengesellschaft
Brahms Diagnostica USA
Branan Medical
CARE Diagnostica
Calypte Biomedical
Cardinal Health
Cepheid
Chembio Diagnostic Systems
Chempaq
Chiron
Cholestech
Church & Dwight
CH Werfen/Werfen Life
Cigna
Claros Diagnostics
Clinical Data
Concateno
Confirm Biosciences
Cozart Bioscience
CVS Caremark
Daktari Technologies
Dexcom
Diabetech
Diagnostic Technology
Diesse Diagnostica
Disney Enterprises
DNA Direct
Drew Scientific
Dr. Langer Medical
Drug Free Enterprises/ Express Diagnostics International
EarlyPregnancyTests.com
Echo Therapeutics
Edwards Lifesciences
Edwards Medical Supply
Ekos
Eli Lilly and Company
Elitech Group
Embroytech Labs
Enterix
Epocal
EPS Biotechnology
Eumed Biotechnology
Eurolyser Diagnostica
Enigma Diagnostics
Exact Sciences
F. Hoffmann-La Roche
Franklin Diagnostics
Fujirebio
GDS Technology
GE Medical Systems
GenBio
Gen-Probe
Genzyme
Germaine Laboratories
Geron
GlaxoSmithKline
GlucoLight
Glucostats System
GluMetrics
Genexo Sp. z o.o.
GlySens
Great Basin Scientific
HandyLab
Healthpia
Helena Laboratories
Hema Diagnostic Systems
HemoCue
HemoSonics
Hemosure
Henry Schein
Hiedelberger Medical Marketing
Hitachi
Hologic
Home Access Health
Home Diagnostics
HomeDrugTestingKit.com
Home Health Testing
MLSC
Honeywell International
Horiba
HuBit
Humasis
Hycor Biomedical
IDEXX Laboratories
Immunostics
Infectio Diagnostic
InLight Solutions
Innotrac Diagnostics
Inova LAB
Instrumentation Laboratory
Insulet
Intec Products
Integrity Applications
Intel Corporation
IntelliGender
International Immunodiagnostics
IRIS International
International Stem Cell
International Technidyne
Invacare
Inverness Medical Innovations
Iquum
i-sens
ISIS Pharmaceuticals
Itamar Medical
Jant Pharmacal
J. Mitra
Johnson & Johnson
Korea Telecom
Kyoto Daiichi Kagaku
LabNOW
Landmark Diagnostics
Lein Applied Diagnostics
LifeScan/Johnson&Johnson
LighTouch Medical
Lobeck Medical
LRE Relais + Elektronik
Luminous Medical
3M
Magellan Biosciences
Mainline Technology
Maxwell Sensors
MaybeMOM
mBio Diagnostics
McKesson
MDY Healthcare
Medarex
Medica
Medical Automation Systems
Medi-Lab
Medimmune
Medimpex United
Medmira
Medonic
Medtox Scientific
Medtronic
Medtronic Blood Management
Merck & Company
Meridian Bioscience
MicroIslet
Mindray Medical International
Mitsubishi Chemical
Moore Medical
Nano-Ditech
Nanogen
Nano Entek
New Horizons Diagnostics
Noble Medical
Northrop Grumman
Nova Biomedical
Novocell
Omega Pharma
Opti Medical
OraSure Technologies
Orgenics
OrSense
Ortho Clinical Diagnostics
Osmetech
Oxoid
Panasonic Shikoku Electronics
PATH
Permaxim
Pfizer
Phadia
Phamatech
Polymedco
Polymer Technology Systems
Preventx
Princeton BioMeditech
Procter & Gamble
Prodesse
PSS World Medical
QBC Diagnostics/The Drucker Company
Qualigen
Quest Diagnostics
Quidel
Radiometer International
Redwood Biotech
ReLIA Diagnostic Systems
ReLIA Biotechnologies
Remel
ReNeuron
Response Biomedical
Rite-Aid
Roche Diagnostics
Rohto Pharmaceutical
Royal Philips Electronics
SA Scientific
Sacks Medical
Sanitoets Closed Corp/Sallamander Concepts
Sanvita
Sanwa Kaguku Kenkyusho
Schering Plough
Sensile Medical
Sensors for Medicine and Science
Separation Technology
Seradyn
Spectral Diagnostics
Sphere Medical
Stanbio Laboratory
Stem Cells
Standard Diagnostics
Swiss Precision Diagnostics
Synova
Syntron
Sysmex
T2 Biosystems
Taidoc
Takeda Pharmaceutical
Target
Techno Medica
Teco Diagnostics
Terumo
Thermo Fisher Scientific
Thoratec
ThromboVision
Tianjin New Bay Bioresearch
TKNO
Tosoh
Trinity Biotech
TwistDx
Tyson Bioresearch
U.S. Diagnostics
Veralight
Visgeneer
Visual Pathways
Vital Diagnostics
Vivacta
VivoMedical
Walgreen Company
Walmart Stores
Wampole Laboratories
X-Bar Diagnostic Systems
YD Diagnostics
Yellow Springs Instruments
Yu.Sys
Zetek

+ MORE

*** This is a partial list of companies, for a full listing request it ***

Other Ways To Purchase:

Call: 714-847-3540

Email Sales

* Single License allows for report sharing within one company location.
** Corporate License allows for report sharing within all company locations.

This report is listed in the following markets:
Cardiovascular, Diagnostics, Endocrine and Patient Management